Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology

E-ISSN： 1873-4316|13|11|2184-2220

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.11, 2012-09, pp. : 2184-2220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center

Current Pharmaceutical Design, Vol. 8, Iss. 20, 2002-09 ,pp. : 1809-1814

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signalling Pathways in Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 170-175

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of osteoclast function and pathways

By Broadhead Matthew L Clark Jonathan CM Dass Crispin R Choong Peter FM Myers Damian E

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 169-181

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targeting of Apoptotic Pathways in Cancer

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1361-1369

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting signalling pathways for the treatment of multiple myeloma

By Podar Klaus Hideshima Teru Chauhan Dharminder Anderson Kenneth C

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 359-381

Informa Healthcare

Access to resources Recommend Favorite